Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Biobanking Services Market is estimated to reach at a CAGR of 17.4% during the forecast period (2024-2031). Biobanking Services Market Size, Share & Trends Report, 2031 [Latest Overview] DATAM Intelligence published new research on Global Biobanking Services covering micro level of analysis by competitors and key business segments (2024-2031).
The biobanking equipment market size is expected to reach US$ 6.34 Bn by 2030, from US$ 2.98 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 11.4% during the forecast period.
1 Introduction The infusion of T cells engineered to express chimeric antigen receptors (CARs) was first authorized by the United States Food and Drug Administration (FDA) to treat B-cell acute lymphoblastic leukemia (ALL) in the year 2017 (1, 2). Although CAR-T technology has demonstrated success in treating several cancer types (3), it presents certain limitations such as occasionally causing cytokine release syndrome (CRS) or immune effector cell-associated neurotoxicity syndrome (ICANS) (4).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
